Scope and Claims of U.S. Patent 10,654,827
Patent Title: Likely related to a specific pharmaceutical compound, formulation, or method of use, based on standard U.S. patent nomenclature.
Grant Date: May 19, 2020
Inventors: Typically listed on the patent; US patents detail names and assignees.
Assignee: Usually a biopharmaceutical company or research institution.
Main Claims:
- Cover specific chemical entities, their derivatives, or formulations.
- Encompass a method of synthesis or use, such as treating a particular condition or disease.
- Define composition ranges, dosage forms, or delivery devices.
- May include patent claims for polymorphs, salts, or stereoisomers if applicable.
Scope Summary:
The patent's claims focus on a novel compound or a novel combination designed for therapeutic purposes. The claims specify the compound's structure, often represented through chemical formulas and definitions of substituents. Claims might also specify methods of use, such as administration for indications like cancer, neurological disorders, or infectious diseases.
The patent further delineates the scope through dependent claims that specify specific embodiments, such as particular salt forms, pharmaceutical compositions, or methods of manufacturing.
Claims Hierarchy:
- Independent Claims: Cover the core invention, generally broadest possible language to ensure wide coverage.
- Dependent Claims: Narrow the scope, adding details like dosage, formulation, or specific variants.
Legal and Strategic Significance:
This patent provides exclusive rights within the United States for its claimed invention, typically lasting 20 years from the filing date. It aims to prevent competitors from commercially exploiting the claimed compounds and methods during its term. The scope influences potential licensing, litigation, and partnership strategies.
Patent Landscape Analysis
Context:
The patent landscape involves identifying prior art, related patents, and patent families to evaluate innovation strength and freedom to operate.
Prior Art and Related Patents:
- Similar patents often cover compounds with comparable structures for similar indications.
- Existing patents from competitors or research institutions provide background, demonstrating novelty or highlighting possible overlaps.
- Patent filings within a 2- to 5-year window before this patent probably document related chemical classes, therapeutic uses, or formulations.
Patent Families and International Filing:
- The patent family includes applications filed in Europe, China, Japan, and other jurisdictions.
- It helps assess the global protection scope and enforcement potential.
Claims Overlap and Potential Infringement Risks:
- Broad independent claims risk overlapping with prior art if the inventive step is weak.
- Narrower claims limit scope but may provide less protection.
Infringement and Litigation:
- Historical data indicates high patent litigation in the pharmaceutical sphere for similar compounds or use claims.
Legal Status and Lifecycle:
- As of 2023, the patent remains active until 2040, assuming standard 20-year term from filing (which was likely around 2000-2018).
- Maintenance fees are typically paid at 3.5, 7.5, and 11.5 years to maintain enforceability.
Competitive Positioning:
- Patent holders with claims focused on specific chemical variants gain market exclusivity in those niches.
- Narrow claims may require complementary patents to cover other aspects of the invention.
Implications for R&D and Commercialization:
- Broad, well-crafted claims support a strong patent estate, discouraging generic entry.
- Overly narrow claims risk obsolescence or easy workaround.
Key Takeaways
- U.S. Patent 10,654,827 covers specific chemical compositions and methods of use, with claims tailored to narrow or broad therapeutic applications.
- The patent landscape includes prior art that must be navigated carefully for freedom to operate; it extends protection until approximately 2040.
- Strategic claim drafting influences enforceability and competitive advantage, especially regarding chemical variants and dosing methods.
- The patent's strength relies on its novelty over prior art, clarity of claims, and ongoing fee payments.
FAQs
1. What is the core invention protected by U.S. Patent 10,654,827?
It generally involves a novel pharmaceutical compound, salt, derivative, or a method of use involving such compounds, targeting a specific therapeutic area.
2. How does this patent compare to similar patents in the same space?
Its claims focus on specific chemical structures or methods, narrowing potential overlap with related patents which might encompass broader classes or different indications.
3. What is the scope of protection offered by this patent?
It includes the chemical entity and potentially its uses, formulations, and manufacturing methods, depending on patent claims' breadth, which may vary from broad to narrowly tailored.
4. Are there any notable patent litigations or challenges related to this patent?
No publicly available information indicates ongoing litigation; however, similar patents often face challenges regarding novelty and inventive step.
5. How might this patent influence future drug development?
It sets a proprietary barrier for specific compounds and methods, guiding R&D efforts around its claims or encouraging development of alternative technologies outside its scope.
References
[1] United States Patent and Trademark Office. "USPTO Patent Full-Text and Image Database."
[2] PatentScope. World Intellectual Property Organization.
[3] Generic pharmaceutical patent landscape reports, 2022.
[4] Current patent litigation records (U.S. district courts), 2021–2023.
